102 related articles for article (PubMed ID: 28678324)
1. Screening and identification of a tumor specific methylation phenotype in the colorectal laterally spreading tumor.
Ni HB; Wang FY; Xu J; He XJ; Chen J; Wu Q; Wu JF; Sun YS
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2611-2616. PubMed ID: 28678324
[TBL] [Abstract][Full Text] [Related]
2. Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.
Guo Q; Wang HB; Li YH; Li HF; Li TT; Zhang WX; Xiang SS; Sun ZQ
Med Sci Monit; 2016 Aug; 22():2816-24. PubMed ID: 27506957
[TBL] [Abstract][Full Text] [Related]
3. [The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
Qi J; Zhu YQ; Luo J; Tao WH
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1954-7. PubMed ID: 17923031
[TBL] [Abstract][Full Text] [Related]
4. Analysis of molecular alterations in laterally spreading tumors of the colorectum.
Sugai T; Habano W; Takagi R; Yamano H; Eizuka M; Arakawa N; Takahashi Y; Yamamoto E; Kawasaki K; Yanai S; Ishida K; Suzuki H; Matsumoto T
J Gastroenterol; 2017 Jun; 52(6):715-723. PubMed ID: 27704264
[TBL] [Abstract][Full Text] [Related]
5. [Wif-1 methylation and β-catenin expression in colorectal serrated lesions].
Fang Y; Wang L; Zhang Y; Ge C; Xu C
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):15-9. PubMed ID: 24713243
[TBL] [Abstract][Full Text] [Related]
6. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
[TBL] [Abstract][Full Text] [Related]
8. Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma.
Nosho K; Yamamoto H; Takahashi T; Mikami M; Hizaki K; Maehata T; Taniguchi H; Yamaoka S; Adachi Y; Itoh F; Imai K; Shinomura Y
Hum Pathol; 2008 May; 39(5):767-75. PubMed ID: 18284934
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide DNA methylation profiling of primary colorectal laterally spreading tumors identifies disease-specific epimutations on common pathways.
Zhu L; Yan F; Wang Z; Dong H; Bian C; Wang T; Yu E; Li J
Int J Cancer; 2018 Nov; 143(10):2488-2498. PubMed ID: 30183087
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of laterally spreading tumors.
Minemura S; Tanaka T; Arai M; Okimoto K; Oyamada A; Saito K; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Kishimoto T; Yokosuka O
BMC Gastroenterol; 2015 Jun; 15():64. PubMed ID: 26048755
[TBL] [Abstract][Full Text] [Related]
11. Methylation epigenotypes and genetic features in colorectal laterally spreading tumors.
Sakai E; Ohata K; Chiba H; Matsuhashi N; Doi N; Fukushima J; Endo H; Takahashi H; Tsuji S; Yagi K; Matsusaka K; Aburatani H; Nakajima A; Kaneda A
Int J Cancer; 2014 Oct; 135(7):1586-95. PubMed ID: 24590867
[TBL] [Abstract][Full Text] [Related]
12. Ectopic Gastric and Intestinal Phenotypes, Neuroendocrine Cell Differentiation, and SOX2 Expression Correlated With Early Tumor Progression in Colorectal Laterally Spreading Tumors.
Katano T; Mizoshita T; Tsukamoto H; Nishie H; Inagaki Y; Hayashi N; Nomura S; Ozeki K; Okamoto Y; Shimura T; Mori Y; Kubota E; Tanida S; Kataoka H; Kuno T; Takahashi S; Joh T
Clin Colorectal Cancer; 2017 Jun; 16(2):141-146. PubMed ID: 27816419
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.
Voorham QJ; Janssen J; Tijssen M; Snellenberg S; Mongera S; van Grieken NC; Grabsch H; Kliment M; Rembacken BJ; Mulder CJ; van Engeland M; Meijer GA; Steenbergen RD; Carvalho B
BMC Cancer; 2013 Dec; 13():603. PubMed ID: 24350795
[TBL] [Abstract][Full Text] [Related]
14. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Role of RASSF1A, SOX17 and Wif-1 Promoter Methylation Status in Cell-Free DNA of Advanced Gastric Cancer Patients.
Karamitrousis EI; Balgkouranidou I; Xenidis N; Amarantidis K; Biziota E; Koukaki T; Trypsianis G; Karayiannakis A; Bolanaki H; Kolios G; Lianidou E; Kakolyris S
Technol Cancer Res Treat; 2021; 20():1533033820973279. PubMed ID: 33928818
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
[TBL] [Abstract][Full Text] [Related]
17. [Methylation status of PCDH10 and RASSF1A gene promoters in colorectal cancer].
Li M; Yan DG; Liu JL
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(6):456-9. PubMed ID: 26875923
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance.
Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Saadallah-Kallel A; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2014 Aug; 35(8):7975-82. PubMed ID: 24833087
[TBL] [Abstract][Full Text] [Related]
20. Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer.
Alvarez C; Tapia T; Cornejo V; Fernandez W; Muñoz A; Camus M; Alvarez M; Devoto L; Carvallo P
Mol Carcinog; 2013 Jun; 52(6):475-87. PubMed ID: 22315090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
